Alexander Statement on FDA Regenerative Medicine Guidance

Posted on November 16, 2017

WASHINGTON, Nov. 16, 2017 – Senate health committee Chairman Lamar Alexander (R-Tenn.) today made the following statement about new Food and Drug Administration guidance on regenerative medicine:  

“I am glad Commissioner Gottlieb is implementing the 21st Century Cures Act in such a way that Americans can access the near-miracles regenerative medicine can provide while ensuring bad actors don’t take advantage of the hope and promise in this field to harm or defraud patients looking for help.”